Genomic organization and evolution of double minutes/homogeneously staining regions with MYC amplification in human cancer

Nucleic Acids Research

Volumn 42, Issue 14, 2014, Pages 9131-9145

  L'Abbate, Alberto ^a   Macchia, Gemma ^a   D'Addabbo, Pietro ^a   Lonoce, Angelo ^a   Tolomeo, Doron ^a   Trombetta, Domenico ^b   Kok, Klaas ^c   Bartenhagen, Christoph ^d   Whelan, Christopher W ^e   Palumbo, Orazio ^b   Severgnini, Marco ^f   Cifola, Ingrid ^f   Dugas, Martin ^d   Carella, Massimo ^b   De Bellis, Gianluca ^f   Rocchi, Mariano ^a   Carbone, Lucia ^e   Storlazzi, Clelia Tiziana ^a  

^a UNIVERSITY OF BARI   (Italy)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e Oregon National Primate Center   (United States)

^f INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

AMPLICON; ARTICLE; BIOINFORMATICS; CHROMOSOME; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DOUBLE MINUTES CHROMOSOME; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE AMPLIFICATION; GENE EXPRESSION; HOMOGENEOUSLY STAINING REGION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR EVOLUTION; NUCLEIC ACID STRUCTURE; NUCLEOTIDE SEQUENCE; ONCOGENE MYC; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMOSOMES, HUMAN; EVOLUTION, MOLECULAR; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUSION; GENES, MYC; GENES, NEOPLASM; GENOME, HUMAN; HL-60 CELLS; HUMANS; NEOPLASMS;

EID: 84906228209     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku590     Document Type: Article

References (61)

1. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (2014)Mitelman, F., Johansson, B. and Mertens, F. (Eds.), http://cgap.nci.nih. gov/Chromosomes/Mitelman.
2. Vukovic, B., Beheshti, B., Park, P., Lim, G., Bayani, J., Zielenska, M. and Squire, J.A. (2007) Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer. Cytogenet. Genome Res., 116, 1-11.
3. Carroll, S.M., DeRose, M.L., Gaudray, P., Moore, C.M., Needham-Vandevanter, D.R., Von Hoff, D.D. and Wahl, G.M. (1988) Double minute chromosomes can be produced from precursors derived from a chromosomal deletion. Mol. Cell. Biol., 8, 1525-1533.
4. Storlazzi, C.T., Fioretos, T., Surace, C., Lonoce, A., Mastrorilli, A., Strombeck, B., D'Addabbo, P., Iacovelli, F., Minervini, C., Aventin, A. et al. (2006) MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum. Mol. Genet., 15, 933-942.
5. Storlazzi, C.T., Lonoce, A., Guastadisegni, M.C., Trombetta, D., D'Addabbo, P., Daniele, G., L'Abbate, A., Macchia, G., Surace, C., Kok, K. et al. (2010) Gene amplification as double minutes or homogeneously staining regions in solid tumors: origin and structure. Genome Res., 20, 1198-1206.
6. Gibaud, A., Vogt, N., Hadj-Hamou, N.S., Meyniel, J.P., Hupe, P., Debatisse, M. and Malfoy, B. (2010) Extrachromosomal amplification mechanisms in a glioma with amplified sequences from multiple chromosome loci. Hum. Mol. Genet., 19, 1276-1285.
7. Korbel, J.O. and Campbell, P.J. (2013) Criteria for inference of chromothripsis in cancer genomes. Cell, 152, 1226-1236.
8. Stephens, P.J., Greenman, C.D., Fu, B., Yang, F., Bignell, G.R., Mudie, L.J., Pleasance, E.D., Lau, K.W., Beare, D., Stebbings, L.A. et al. (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell, 144, 27-40.
9. Rausch, T., Jones, D.T., Zapatka, M., Stutz, A.M., Zichner, T., Weischenfeldt, J., Jager, N., Remke, M., Shih, D., Northcott, P.A. et al. (2012) Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell, 148, 59-71.
10. de Leij, L., Postmus, P.E., Buys, C.H., Elema, J.D., Ramaekers, F., Poppema, S., Brouwer, M., van der Veen, A.Y., Mesander, G. and The, T.H. (1985) Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. Cancer Res., 45, 6024-6033.
11. Zijlstra, J.G., de Vries, E.G. and Mulder, N.H. (1987) Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res., 47, 1780-1784.
12. Gallagher, R., Collins, S., Trujillo, J., McCredie, K., Ahearn, M., Tsai, S., Metzgar, R., Aulakh, G., Ting, R., Ruscetti, F. et al. (1979) Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood, 54, 713-733.
13. Quinn, L.A., Moore, G.E., Morgan, R.T. and Woods, L.K. (1979) Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res., 39, 4914-4924.
14. Lin, C.C., Alitalo, K., Schwab, M., George, D., Varmus, H.E. and Bishop, J.M. (1985) Evolution of karyotypic abnormalities and C-MYC oncogene amplification in human colonic carcinoma cell lines. Chromosoma, 92, 11-15.
15. Rausch, T., Zichner, T., Schlattl, A., Stutz, A.M., Benes, V. and Korbel, J.O. (2012) DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics, 28, i333-i339.
16. Chen, K., Wallis, J.W., McLellan, M.D., Larson, D.E., Kalicki, J.M., Pohl, C.S., McGrath, S.D., Wendl, M.C., Zhang, Q., Locke, D.P. et al. (2009) BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat. Methods, 6, 677-681.
17. Quinlan, A.R., Clark, R.A., Sokolova, S., Leibowitz, M.L., Zhang, Y., Hurles, M.E., Mell, J.C. and Hall, I.M. (2010) Genome-wide mapping and assembly of structural variant breakpoints in the mouse genome. Genome Res., 20, 623-635.
18. Sindi, S., Helman, E., Bashir, A. and Raphael, B.J. (2009) A geometric approach for classification and comparison of structural variants. Bioinformatics, 25, i222-i230.
19. Quinlan, A.R. and Hall, I.M. (2010) BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics, 26, 841-842.
20. Abecasis, G.R., Auton, A., Brooks, L.D., DePristo, M.A., Durbin, R.M., Handsaker, R.E., Kang, H.M., Marth, G.T. and McVean, G.A. (2012) An integrated map of genetic variation from 1,092 human genomes. Nature, 491, 56-65.
21. Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A. and Speleman, F. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3, RESEARCH0034.
22. Pfaffl, M.W., Horgan, G.W. and Dempfle, L. (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res., 30, e36.
23. Schwab, M., Klempnauer, K.H., Alitalo, K., Varmus, H. and Bishop, M. (1986) Rearrangement at the 5′ end of amplified c-myc in human COLO 320 cells is associated with abnormal transcription. Mol. Cell. Biol., 6, 2752-2755.
24. Gajduskova, P., Snijders, A.M., Kwek, S., Roydasgupta, R., Fridlyand, J., Tokuyasu, T., Pinkel, D. and Albertson, D.G. (2007) Genome position and gene amplification. Genome Biol., 8, R120.
25. Vogt, N., Lefevre, S.H., Apiou, F., Dutrillaux, A.M., Cor, A., Leuraud, P., Poupon, M.F., Dutrillaux, B., Debatisse, M. and Malfoy, B. (2004) Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas. Proc. Natl Acad. Sci. U.S.A., 101, 11368-11373.
26. Iwakawa, R., Takenaka, M., Kohno, T., Shimada, Y., Totoki, Y., Shibata, T., Tsuta, K., Nishikawa, R., Noguchi, M., Sato-Otsubo, A. et al. (2013) Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer. Genes Chromosomes Cancer, 52, 802-816.
27. Northcott, P.A., Shih, D.J., Peacock, J., Garzia, L., Morrissy, A.S., Zichner, T., Stutz, A.M., Korshunov, A., Reimand, J., Schumacher, S.E. et al. (2012) Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature, 488, 49-56.
28. Moore, J.K. and Haber, J.E. (1996) Cell cycle and genetic requirements of two pathways of nonhomologous end-joining repair of double-strand breaks in Saccharomyces cerevisiae. Mol. Cell. Biol., 16, 2164-2173.
29. Hastings, P.J., Ira, G. and Lupski, J.R. (2009) A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet., 5, e1000327.
30. Sanborn, J.Z., Salama, S.R., Grifford, M., Brennan, C.W., Mikkelsen, T., Jhanwar, S., Katzman, S., Chin, L. and Haussler, D. (2013) Double minute chromosomes in glioblastoma multiforme are revealed by precise reconstruction of oncogenic amplicons. Cancer Res., 73, 6036-6045.
31. Gibaud, A., Vogt, N., Brison, O., Debatisse, M. and Malfoy, B. (2013) Characterization at nucleotide resolution of the homogeneously staining region sites of insertion in two cancer cell lines. Nucleic Acids Res., 41, 8210-8219.
32. Harada, S., Sekiguchi, N. and Shimizu, N. (2011) Amplification of a plasmid bearing a mammalian replication initiation region in chromosomal and extrachromosomal contexts. Nucleic Acids Res., 39, 958-969.
33. Campbell, P.J., Stephens, P.J., Pleasance, E.D., O'Meara, S., Li, H., Santarius, T., Stebbings, L.A., Leroy, C., Edkins, S., Hardy, C. et al. (2008) Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat. Genet., 40, 722-729.
34. Shimizu, N., Shingaki, K., Kaneko-Sasaguri, Y., Hashizume, T. and Kanda, T. (2005) When, where and how the bridge breaks: anaphase bridge breakage plays a crucial role in gene amplification and HSR generation. Exp. Cell Res., 302, 233-243.
35. Arlt, M.F., Mulle, J.G., Schaibley, V.M., Ragland, R.L., Durkin, S.G., Warren, S.T. and Glover, T.W. (2009) Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. Am. J. Hum. Genet., 84, 339-350.
36. Mizuno, K., Miyabe, I., Schalbetter, S.A., Carr, A.M. and Murray, J.M. (2013) Recombination-restarted replication makes inverted chromosome fusions at inverted repeats. Nature, 493, 246-249.
37. Blumrich, A., Zapatka, M., Brueckner, L.M., Zheglo, D., Schwab, M. and Savelyeva, L. (2011) The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers. Hum. Mol. Genet., 20, 1488-1501.
38. Mrasek, K., Schoder, C., Teichmann, A.C., Behr, K., Franze, B., Wilhelm, K., Blaurock, N., Claussen, U., Liehr, T. and Weise, A. (2010) Global screening and extended nomenclature for 230 aphidicolin-inducible fragile sites, including 61 yet unreported ones. Int. J. Oncol., 36, 929-940.
39. Network., C.G.A. (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330-337.
40. Storlazzi, C.T., Fioretos, T., Paulsson, K., Strombeck, B., Lassen, C., Ahlgren, T., Juliusson, G., Mitelman, F., Rocchi, M. and Johansson, B. (2004) Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies. Hum. Mol. Genet., 13, 1479-1485.
41. Ji, W., Bian, Z., Yu, Y., Yuan, C., Liu, Y., Yu, L., Li, C., Zhu, J., Jia, X., Guan, R. et al. (2014) Expulsion of micronuclei containing amplified genes contributes to a decrease in double minute chromosomes from malignant tumor cells. Int. J. Cancer, 134, 1279-1288.
42. Blyth, K., Cameron, E.R. and Neil, J.C. (2005) The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer, 5, 376-387.
43. Sun, J., Karoulia, Z., Wong, E.Y., Ahmed, M., Itoh, K. and Xu, P.X. (2013) The phosphatase-transcription activator EYA1 is targeted by anaphase-promoting complex/Cdh1 for degradation at M-to-G1 transition. Mol. Cell. Biol., 33, 927-936.
44. Davies, M.A. (2011) Regulation, role, and targeting of Akt in cancer. J. Clin. Oncol., 29, 4715-4717.
45. Feldman, A.L., Dogan, A., Smith, D.I., Law, M.E., Ansell, S.M., Johnson, S.H., Porcher, J.C., Ozsan, N., Wieben, E.D., Eckloff, B.W. et al. (2011) Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood, 117, 915-919.
46. Bernard-Pierrot, I., Gruel, N., Stransky, N., Vincent-Salomon, A., Reyal, F., Raynal, V., Vallot, C., Pierron, G., Radvanyi, F. and Delattre, O. (2008) Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res., 68, 7165-7175.
47. Lee, W., Jiang, Z., Liu, J., Haverty, P.M., Guan, Y., Stinson, J., Yue, P., Zhang, Y., Pant, K.P., Bhatt, D. et al. (2010) The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature, 465, 473-477.
48. Pleasance, E.D., Stephens, P.J., O'Meara, S., McBride, D.J., Meynert, A., Jones, D., Lin, M.L., Beare, D., Lau, K.W., Greenman, C. et al. (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature, 463, 184-190.
49. Nagoshi, H., Taki, T., Hanamura, I., Nitta, M., Otsuki, T., Nishida, K., Okuda, K., Sakamoto, N., Kobayashi, S., Yamamoto-Sugitani, M. et al. (2012) Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality. Cancer Res., 72, 4954-4962.
50. Kim, H.P., Cho, G.A., Han, S.W., Shin, J.Y., Jeong, E.G., Song, S.H., Lee, W.C., Lee, K.H., Bang, D., Seo, J.S. et al. (2013) Novel fusion transcripts in human gastric cancer revealed by transcriptome analysis. Oncogene., doi:10.1038/onc.2013.490.
51. Borg, A., Baldetorp, B., Ferno, M., Olsson, H. and Sigurdsson, H. (1992) c-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int. J. Cancer, 51, 687-691.
52. You, L., Chang, D., Du, H.Z. and Zhao, Y.P. (2011) Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. Biochem. Biophys. Res. Commun., 407, 1-6.
53. Xu, P.X., Cheng, J., Epstein, J.A. and Maas, R.L. (1997) Mouse Eya genes are expressed during limb tendon development and encode a transcriptional activation function. Proc. Natl Acad. Sci. U.S.A., 94, 11974-11979.
54. Kim, D., Sun, M., He, L., Zhou, Q.H., Chen, J., Sun, X.M., Bepler, G., Sebti, S.M. and Cheng, J.Q. (2010) A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation. J. Biol. Chem., 285, 8383-8394.
55. Wilding, J.L. and Bodmer, W.F. (2014) Cancer cell lines for drug discovery and development. Cancer Res., 74, 2377-2384.
56. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A.A., Kim, S., Wilson, C.J., Lehar, J., Kryukov, G.V., Sonkin, D. et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 483, 603-607.
57. Leal, M.F., Calcagno, D.Q., Borges da Costa Jde, F., Silva, T.C., Khayat, A.S., Chen, E.S., Assumpcao, P.P., de Arruda Cardoso Smith, M. and Burbano, R.R. (2011) MYC, TP53, and chromosome 17 copy-number alterations in multiple gastric cancer cell lines and in their parental primary tumors. J. Biomed. Biotechnol., doi:10.1155/2011/631268.
58. Sos, M.L., Dietlein, F., Peifer, M., Schottle, J., Balke-Want, H., Muller, C., Koker, M., Richters, A., Heynck, S., Malchers, F. et al. (2012) A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proc. Natl Acad. Sci. U.S.A., 109, 17034-17039.
59. Solomon, D.A., Kim, J.S., Ressom, H.W., Sibenaller, Z., Ryken, T., Jean, W., Bigner, D., Yan, H. and Waldman, T. (2009) Sample type bias in the analysis of cancer genomes. Cancer Res., 69, 5630-5633.
60. Caren, H., Erichsen, J., Olsson, L., Enerback, C., Sjoberg, R.M., Abrahamsson, J., Kogner, P. and Martinsson, T. (2008) High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene. BMC Genomics, 9, 353.
61. Fix, A., Lucchesi, C., Ribeiro, A., Lequin, D., Pierron, G., Schleiermacher, G., Delattre, O. and Janoueix-Lerosey, I. (2008) Characterization of amplicons in neuroblastoma: high-resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes. Genes Chromosomes Cancer, 47, 819-834.